Skip to main content

View full-text article in PMC

. 2012 May 1;12:160. doi: 10.1186/1471-2407-12-160

Table 1.

The association between prevalent genotypes of human papilloma virus persistent positivity and cervical lesions


Pathological stage	No. 15257	HPV +	χ²	P	Multiple HPV(+)	χ²	P	HPV 16+	χ²	P	HPV 58+	χ²	P	HPV 18+	χ²	P	HPV 52+	χ²	P	HPV 33+	χ²	P
Stage 1
normal	10477	262	519.846	0.0001	98	404.940	0.0001	43	139.334	0.0001	59	494.956	0.0001	83	45.796	0.0001	55	59.537	0.0001	47	94.149	0.0001
CINI	2068	283	519.846	0.0001	162	404.940	0.0001	62	139.334	0.0001	155	494.956	0.0001	51	45.796	0.0001	45	59.537	0.0001	52	94.149	0.0001
Stage 2
CINI	2068	283	2054.183	0.0001	162	107.486	0.0001	62	180.252	0.0001	155	0.444	0.522	51	5.929	0.016	45	4.881	0.031	52	3.019	0.094
CINII/III	1604	1426	2054.183	0.0001	311	107.486	0.0001	247	180.252	0.0001	111	0.444	0.522	62	5.929	0.016	54	4.881	0.031	56	3.019	0.094
Stage 3
CINII/III	1604	1426	0.53	0.5	311	1.245	0.271	247	0.046	0.829	111	0.321	0.571	62	6.374	0.013	54	1.999	0.157	56	0.677	0.378
Cervical cancer	1108	975	0.53	0.5	196	1.245	0.271	174	0.046	0.829	83	0.321	0.571	66	6.374	0.013	49	1.999	0.157	42	0.677	0.378